13F filer · CIK 1040273 ↗
Third Point
You are looking at Q3 2016. See the latest, Q2 2026 →
Reported value
$11.50B
+9.6% on the quarter before
Positions
38
9 new · 11 sold out
Top 10
62.8%
of the value
Est. gain
+$457.1M
on stocks held all quarter
Est. return
+5.4%
on those stocks since Q2 2016
Positions as of Sep 30, 2016, from Third Point's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.
Largest buys
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$282.6MNew · 0.0% → 2.5%+2,500,000 shares
- Alibaba~$275.1MNew · 0.0% → 2.4%+2,600,000 shares
- Humana Inc~$247.6MNew · 0.0% → 2.2%+1,400,000 shares
- Meta~$218.1MAdded · 4.1% → 6.1%+1,700,000 shares
- St Jude Med Inc~$207.4MNew · 0.0% → 1.8%+2,600,000 shares
- Conagra Foods Inc~$200.2MNew · 0.0% → 1.7%+4,250,000 shares
- Monsanto Co New~$173.7MAdded · 2.0% → 3.3%+1,700,000 shares
- Visa Inc.~$173.7MNew · 0.0% → 1.5%+2,100,000 shares
- General Dynamics Corp~$154.4MAdded · 0.5% → 1.8%+994,900 shares
- Williams Companies~$122.9MNew · 0.0% → 1.1%+4,000,000 shares
Largest sells
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Allergan Plc~$256.8MCut · 10.8% → 7.6%−1,115,000 shares
- Lowes Cos Inc~$237.5MSold out · 2.3% → 0.0%−3,000,000 shares
- Sealed Air Corp New~$206.9MSold out · 2.0% → 0.0%−4,500,000 shares
- Yum Brands Inc~$181.6MCut · 2.0% → 0.4%−2,000,000 shares
- E M C Corp Mass~$163.0MSold out · 1.6% → 0.0%−6,000,000 shares
- Charter Communications Inc N~$121.5MCut · 3.2% → 2.3%−450,000 shares
- Mohawk Inds Inc~$120.2MCut · 2.7% → 1.6%−600,000 shares
- Activision Blizzard Inc~$118.9MSold out · 1.1% → 0.0%−3,000,000 shares
- Allergan PlcCALL~$115.5MSold out · 1.1% → 0.0%−500,000 underlying
- Coca Cola European Partners~$96.4MSold out · 0.9% → 0.0%−2,700,000 shares
Holdings
As of Sep 30, 2016. Changes are in shares against Jun 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Intl IncCOM · shares 0% · price +5.3% | 21.5% | $2.47B | +$123.5M | ||||||||
| Dow Chem CoCOM · shares 0% · price +4.3% | 9.0% | $1.04B | +$42.4M | ||||||||
| Allergan PlcSHS · shares −23% · price −0.3% | 7.6% | $871.7M | −$3.0M | ||||||||
| MetaCL A · shares +45% · price +12.2% | 6.1% | $699.1M | +$52.5M | ||||||||
| AlphabetCAP STK CL A · shares +38% · price +14.3% | 3.8% | $442.2M | +$40.2M | ||||||||
| Monsanto Co NewCOM · shares +85% · price −1.2% | 3.3% | $378.1M | −$2.4M | ||||||||
| Constellation Brands IncCL A · shares +10% · price +0.7% | 3.2% | $366.3M | +$2.2M | ||||||||
| Danaher Corp DelCOM · shares +17% · price −22.4% | 3.1% | $352.8M | −$87.0M | ||||||||
| Transdigm Group IncCOM · shares 0% · price +9.6% | 2.8% | $327.0M | +$28.8M | ||||||||
| AppleCOM · shares New | 2.5% | $282.6M | — | ||||||||
| AlibabaSPONSORED ADS · shares New | 2.4% | $275.1M | — | ||||||||
| Charter Communications Inc NCL A · shares −31% · price +18.1% | 2.3% | $270.0M | +$41.3M | ||||||||
| SothebysCOM · shares +0.01% · price +38.8% | 2.2% | $253.3M | +$70.7M | ||||||||
| S&P Global IncCOM · shares +25% · price +18.0% | 2.2% | $253.1M | +$30.9M | ||||||||
| Humana IncCOM · shares New | 2.2% | $247.6M | — | ||||||||
| Sherwin Williams CoCOM · shares +25% · price −5.8% | 2.1% | $242.1M | −$11.9M | ||||||||
| Chubb LimitedCOM · shares −23% · price −3.9% | 2.0% | $226.2M | −$9.1M | ||||||||
| Anheuser Busch Inbev Sa/NvSPONSORED ADR · shares −16% · price −0.2% | 1.8% | $210.3M | −$432,000 | ||||||||
| General Dynamics CorpCOM · shares +280% · price +11.4% | 1.8% | $209.5M | +$5.7M | ||||||||
| St Jude Med IncCOM · shares New | 1.8% | $207.4M | — | ||||||||
| Conagra Foods IncCOM · shares New | 1.7% | $200.2M | — | ||||||||
| Molson Coors Brewing CoCL B · shares +70% · price +8.6% | 1.6% | $186.7M | +$8.7M | ||||||||
| Mohawk Inds IncCOM · shares −40% · price +5.6% | 1.6% | $180.3M | +$9.5M | ||||||||
| Shire PlcSPONSORED ADR · shares −5.3% · price +5.3% | 1.5% | $174.5M | +$8.8M | ||||||||
| Visa Inc.COM CL A · shares New | 1.5% | $173.7M | — | ||||||||
| Total · 38 positions | 100% | $11.50B | +$457.1M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2016 to Q3 2016: 29 stocks held throughout, up $457.1M (+5.4%).
- Baxter Intl Inc+$123.5M+5%
- Sothebys+$70.7M+39%
- Meta+$52.5M+12%
- Nomad Hldgs Ltd+$48.6M+48%
- Dow Chem Co+$42.4M+4%
- Allergan Plc−$3.0M−0%
- Enphase Energy Inc−$5.1M−41%
- Chubb Limited−$9.1M−4%
- Sherwin Williams Co−$11.9M−6%
- Danaher Corp Del−$87.0M−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $4.68B+125% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.08B−71% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $7.27B−19% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $8.99B+18% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $7.62B+16% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $6.55B−12% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $7.44B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $7.43B−15% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $8.74B+11% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $7.85B+18% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $6.64B+1% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $6.59B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $6.82B+12% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.11B+2% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.97B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.53B+31% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $4.22B−45% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $7.68B−46% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $14.33B−22% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $18.32B+7% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $17.08B+15% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $14.84B+14% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $12.97B+30% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $10.00B+37% | SEC ↗ |
| Q2 2020 | Aug 17, 2020 | $7.30B+17% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $6.27B−28% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $8.70B+3% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $8.42B−1% | SEC ↗ |
| Q2 2019 | Aug 12, 2019 | $8.54B−5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $8.99B+38% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $6.51B−55% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $14.31B−0% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $14.35B+8% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $13.32B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $13.86B+16% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $11.90B+5% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $11.28B+10% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $10.25B+1% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $10.19B−11% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $11.50B+10% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $10.49B−3% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $10.86B | SEC ↗ |